← Back to Search

Procedure

Microneedling vs Dermabrasion for Facial Scars

N/A
Recruiting
Led By Candace M Water, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients will be 18 years old+ and have a vertical surgical scar in the superior 1/3 of the face (trichion to glabella).
Be older than 18 years old
Must not have
Patients who rate Types 4-6 on the Fitzpatrick scale will be excluded due to risk of poor outcome from dermabrasion.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 7
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at which treatment is best for improving the look of facial surgery scars: microneedling or dermabrasion.

Who is the study for?
This trial is for individuals with recent surgical scars on their face. Participants should be in good health and not have any skin infections or conditions that could interfere with healing.
What is being tested?
The study is testing two techniques to improve the appearance of facial scars: microneedling, which uses fine needles, and dermabrasion, which sands down the skin. The goal is to see which method works better right after surgery.
What are the potential side effects?
Possible side effects may include redness, swelling, pain at the treatment site, infection risk increase, temporary changes in skin coloration, and potential worsening of scarring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and have a surgical scar on the upper part of my face.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My skin type is not between 4 to 6 on the Fitzpatrick scale.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 7 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Global Aesthetic Improvement Scale Scores
Change in Patient and Observer Scar Assessment Scale Scores
Change in Vancouver Scar Scale Scores

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: microneedlingActive Control1 Intervention
microneedling is a form of collagen induction therapy, often used in conjunction with platelet-rich plasma or hyaluronic acid - Patients will receive two treatments, once at 6-8 weeks following facial surgery, and the second at 12-16 weeks following facial surgery
Group II: dermabrasionActive Control1 Intervention
dermabrasion is a technique that improves the skin structure, quality, and appearance of scars through collagen remodeling and reepithelization - Patients will receive the standard of care treatment 6-10 weeks following facial surgery

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,401 Previous Clinical Trials
2,460,275 Total Patients Enrolled
Candace M Water, MDPrincipal InvestigatorWake Forest University Health Sciences
~19 spots leftby Apr 2026